The Written Informed Consent Act directs the Veterans Affairs Department to expand its informed consent requirements to cover additional medication types used to treat veterans. Currently, the VA's informed consent directive applies only to long-term opioid pain therapy, but this bill would extend those same written consent requirements to antipsychotics, stimulants, antidepressants, anxiolytics (anti-anxiety drugs), and narcotics. This means veterans receiving these medications would need to provide documented, written consent after being fully informed about the medications' benefits and risks. The bill affects all veterans treated through the VA healthcare system and requires no new funding—it simply expands an existing VA policy framework. The legislation was introduced in December 2025 and referred to the Senate Committee on Veterans' Affairs.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.